About Enzyme
Enzyme is a company based in San Francisco (United States) founded in 2016 by Jared Seehafer and Jacob Graham was acquired by Greenlight Guru in July 2025.. Enzyme has raised $1.97 million across 2 funding rounds from investors including Greenlight Guru, Refactor Capital and DCVC. The company has 19 employees as of December 31, 2022. Enzyme offers products and services including Enzyme QMS, Document Control, Change Control, and Risk Management. Enzyme operates in a competitive market with competitors including Qualio, MasterControl, Legit, Dot Compliance and Greenlight Guru, among others.
- Headquarter San Francisco, United States
- Employees 19 as on 31 Dec, 2022
- Founders Jared Seehafer, Jacob Graham
-
Sectors
TechnologyHealthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Enzyme Corporation
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$1.97 M (USD)
in 2 rounds
-
Latest Funding Round
$1.85 M (USD), Seed
Jan 18, 2018
-
Investors
Greenlight Guru
& 6 more
-
Employee Count
19
as on Dec 31, 2022
-
Acquired by
Greenlight Guru
(Jul 24, 2025)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Enzyme
Enzyme offers a comprehensive portfolio of products and services, including Enzyme QMS, Document Control, Change Control, and Risk Management. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for document control and compliance in life sciences.
Tool for managing and tracking regulatory documents.
System for overseeing changes in quality processes.
Software for identifying and mitigating risks in products.
Unlock access to complete
Unlock access to complete
Funding Insights of Enzyme
Enzyme has successfully raised a total of $1.97M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $1.85 million completed in January 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Seed — $1.9M
-
First Round
First Round
(01 Jun 2017)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2018 | Amount | Seed - Enzyme | Valuation | Refactor Capital | |
| Jun, 2017 | Amount | Seed - Enzyme | Valuation | Y Combinator |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Enzyme
Enzyme has secured backing from 7 investors, including venture fund and angel investors. Prominent investors backing the company include Greenlight Guru, Refactor Capital and DCVC. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Seed and early-stage investments are made across US and India.
|
Founded Year | Domain | Location | |
|
Venture capital firm focused on multiple sectors
|
Founded Year | Domain | Location | |
|
Digital Health focused VC & Accelerator firm investing in the US
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Enzyme
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Enzyme
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Enzyme Comparisons
Competitors of Enzyme
Enzyme operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Qualio, MasterControl, Legit, Dot Compliance and Greenlight Guru, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Web-based quality management software is delivered for life sciences firms.
|
|
| domain | founded_year | HQ Location |
Provider of governance, risk and compliance solutions for life sciences industries
|
|
| domain | founded_year | HQ Location |
Legit is recognized as a pioneer in privacy and data protection, offering innovative RegTech solutions.
|
|
| domain | founded_year | HQ Location |
Cloud based quality management software
|
|
| domain | founded_year | HQ Location |
Cloud-based quality management software is offered for medical device manufacturers.
|
|
| domain | founded_year | HQ Location |
Cloud-based quality management software is offered for organizational processes.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Enzyme
When was Enzyme founded?
Enzyme was founded in 2016 and raised its 1st funding round 1 year after it was founded.
Where is Enzyme located?
Enzyme is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Who is the current CEO of Enzyme?
Jared Seehafer is the current CEO of Enzyme. They have also founded this company.
Is Enzyme a funded company?
Enzyme is a funded company, having raised a total of $1.97M across 2 funding rounds to date. The company's 1st funding round was a Seed of $120K, raised on Jun 01, 2017.
How many employees does Enzyme have?
As of Dec 31, 2022, the latest employee count at Enzyme is 19.
What does Enzyme do?
Enzyme was founded in 2016 in San Francisco, United States, and operates in the healthcare technology sector. A cloud-based quality management system is offered to medical device and diagnostic companies for managing FDA compliance workflows. Compliance and quality systems are delivered as a service through a web application, supporting operations in gaining and maintaining regulatory adherence.
Who are the top competitors of Enzyme?
Enzyme's top competitors include Qualio, MasterControl and Greenlight Guru.
What products or services does Enzyme offer?
Enzyme offers Enzyme QMS, Document Control, Change Control, and Risk Management.
Who are Enzyme's investors?
Enzyme has 7 investors. Key investors include Greenlight Guru, Refactor Capital, DCVC, Rock Health, and Elizabeth Iorns.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.